About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

New Promising Treatment Options for Parkinson’s Patients

by Raja Nandhini on March 16, 2013 at 6:58 AM
Font : A-A+

 New Promising Treatment Options for Parkinson’s Patients

Dr. Robert A. Hauser of the University of South Florida and his team have identified three new promising treatments for Parkinson's patients. Parkinson's disease, which affects the motor coordination causing shaking and difficulty in movements, has no known cure and only the symptoms can be treated. Dr. Robert Hauser and his team in their studies looked at improving the treatment methodologies by using new drugs.

Study-I

Advertisement

Levodopa, is the commonly used drug to control motor symptoms. This drug remains ineffective for up to six hours between doses. In the first randomized study involving 420 patients, researchers treated the patients with a new trial drug, tozadenant, along with levodopa. After 12 weeks, it was found that the wear-off time was reduced by more than an hour along with reduced involuntary tremors.

Study-II

Another common problem is the sudden drop in blood pressure when the patient stands up from sitting position as norepinephrine, a brain signaling chemical is not released. This often caused the patients to fall. In the next randomized trial involving 225 patients, researchers administered drug droxidopa (L-DOPS) and placebo randomly. After 10 weeks, it was noted that patients on droxidopa were less likely to fall and drop in blood pressure was reduced.
Advertisement

Study -III

In his third study, Hauser examined 321 patients in the early stages of Parkinson's disease who did not respond to dopamine agonist drug, generally given to patients with initial stages of the disease. Patients were randomly assigned to the drug rasagiline or a placebo and at after 18 weeks it was found that the severity of the disease decreased in patients who were on rasagiline.

Dr. Robert A. Hauser will present the findings of the three successful studies at the American Academy of Neurology's 65th Annual Meeting in San Diego next week.

Source: Medindia
Advertisement

Advertisement
Advertisement

Latest Drug News

 Parkinson's Unmet Needs Creates Path for New Entrants into the Market
Addressing the unmet needs of Parkinson's Disease by providing disease-modifying therapies could bring about a major shift in the way that patients are treated.
How Microrobots Could Help Treat Bladder Diseases?
Microrobots could swirl through a person's blood stream, search for targeted areas to treat for various ailments.
How Can Multivitamin Supplements Slow Cognitive Aging?
Supplementation with multivitamins is an inexpensive way for older adults to slow down memory loss.
 Ivosidenib Approved for Acute Myeloid Leukemia & Advanced Cholangiocarcinoma
Some people with an aggressive blood cancer called acute myeloid leukemia (AML) may soon have a new drug option called Ivosidenib that blocks the activity of IDH1 gene.
Sacubitril/valsartan Unleashes Hope for Heart Failure Patients
In case of cardiac failure where the ejection fraction is greater than 40%, sacubitril/valsartan can prove to be quite beneficial
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

New Promising Treatment Options for Parkinson’s Patients Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests